Adult Care Providers
Dr. Clare-Salzler received his Doctor of Medicine and medical training from the State University of New York in Buffalo. He began his research career at the University of California in Los Angeles, where he studied the immunopathogenesis of Type I Diabetes (T1D) in NOD mice, which is the genetic mouse model for T1D. Since transferring to the University of Florida Departments of Immunology, Pathology and Laboratory Medicine and Internal Medicine and Surgery in 1993, Dr. Clare-Salzler has been pursuing his research in T1D diagnosis and management, autoimmune thyroid disease, & other endocrine diseases. He participates in many clinical trials, including the PANDA infant screening program and the Diabetes Prevention Trial for T1D.
Dr. Kenneth Cusi serves as the chief of the adult division of endocrinology, diabetes & metabolism. He oversees all adult outpatient and inpatient endocrinology clinics and consult activities, serves as a mentor for all clinical and laboratory research efforts, and mentors faculty and fellows in the division to help UF&Shands take the next step in becoming an international leader in adult diabetes, metabolism, and obesity. He received his medical degree from the University of Buenos Aires School of Medicine in Argentina and completed his residency at the Center of Medical Education & Clinical Research in Buenos Aires and a clinical fellowship at Baylor College of Medicine in Houston. His experience in diabetes prior to UF was in the department of medicine at the University of Texas Health Science Center at San Antonio for more than 15 years. Cusi is the principal investigator of various ongoing clinical research projects. His grants focus on type 2 diabetes and its complications, particularly in Hispanics.
Dr. Colleen Digman is a graduate of Georgetown University School of Medicine where she recieved her medical degree in May of 2000. Dr. Digman completed her internship at the University of Massachusetts, trained at the New England Medical Center and followed up with a fellowship in Endocrinology and Metabolism at the New England Medical Center from 2003-2005. From 2005-2008, she served as a staff physician in Endocrinology at North Shore Medical Center and then transferred to Valley Regional Hospital in Claremont, NH where she continued as a staff physician from 2008-2010. In 2010, Dr. Digman started with the University of Florida, in the Division of Endocrinology, Diabetes & Metabolism as a Clinical Assistant Professor. For more information on Dr. Digman, including her current research interests, please click here.
Catherine Edwards, MD, FACE
Dr. Edwards currently serves as the Program Director of Endocrinology at the University of Florida. She received her MD from the University of Michigan and subsequently did her Internship, Residency and Chief residency at the University of Florida. She did a three year research fellowship, focusing on lipid biochemistry at the same institution, followed by another year at the University of Michigan working in the area of thyroid receptor molecular biology. She was on the faculty of the Endocrinology division for the next seven years, followed by 15 years in the private practice of Endocrinology in Gainesville, Florida. She recently returned to academics to focus on teaching and clinical work in the division of Endocrinology, Diabetes & Metabolism.
Dr. Quinn is the current director of the Endocrinology Fellowship Program, serves as a Vice-Chair for the university’s Investigational Review Board and as Endocrinology Section Chief for the Gainesville Veterans Administration Medical Center. Dr. Quinn is a published researcher in the fields of growth hormone receptors and, more recently, hypertension, osteoporosis and diabetes. She has been involved in a number of clinical studies in patients with hypertension, osteoporosis and diabetes, focusing predominantly on diabetes and associated lipid abnormalities. Dr. Quinn’s clinical interests include a variety of adult and pediatric general endocrine disorders. She studies in-home intravenous antibiotic programs, and has clinical interests in new therapeutic regimens for achieving a tighter control of diabetes. With her background in pharmacy and therapeutics she is especially interested in controlling diabetes through new therapies, insulin pumps and highly-concentrated U-500 insulin.